L’hépatite virale C en hémodialyse : étude multicentrique ambispective de séroconversion et de prévalence

Bahadi, A.; Maoujoud, Omar; Hassani, Kawtar; Akhmouch, Ismail; Doblali, Taoufik; Allam, Mustapha; Benyahia, M.; Kabbaj, Driss El; Mrani, Saâd; Oualim, Z.

doi:10.1016/j.nephro.2011.07.296

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These data suggest that a moderate difference of anti‐HCV prevalence may exist between northern and southern Morocco. Very high anti‐HCV prevalence rates were observed in patients undergoing haemodialysis (34–68%) and in haemophiliacs (42%) [Benjelloun et al, ; Boulaajaj et al, ; Sekkat et al, ; Bahadi et al, ]. In the haemodialysis subgroup, the incidence of new cases of HCV was assessed among seronegative patients by a follow‐up study at three and six months yielding an incidence of nine new cases per year per 100 haemodialysis patients [Sekkat et al, ].…”

Section: Epidemiology Of Hepatitis C In the Maghreb Regionmentioning

confidence: 99%

Hepatitis C virus infection in the Maghreb region

Ezzikouri

Pineau

Benjelloun

2013

Journal of Medical Virology

View full text Add to dashboard Cite

Hepatitis C is a global health problem with a worldwide prevalence of about 3% (around 170 million people). Hepatitis C virus (HCV) is major concern in the Maghreb countries, Algeria, Libya, Mauritania, Morocco, and Tunisia, but no detailed description of its epidemiology in the region is available. In the present review, a systematic search was undertaken covering HCV data available in peer-reviewed databases as well as institutional reports and regional conference meeting abstracts from the Maghreb countries. Reports written in English and French were included in this analysis. Estimates of national and regional prevalence of HCV infection (based on anti-HCV antibody) and of the size of patient populations were performed. In addition, the molecular features of the circulating viral strains in the region are discussed. A substantial proportion, 1.2-1.9% of the Maghreb inhabitants, have anti-HCV antibodies. Genotype 1b predominates among viral strains in all countries except in Libya, where genotype 4 is dominant as in neighboring Egypt. This epidemiological situation is of significant concern, and requires urgent, broad, and active intervention for the prevention and control of HCV. More specifically, the application of state-of-the-art hygiene procedures and rigorous controls in medical disciplines such as hemodialysis, transfusion, endoscopic procedures, and dentistry is necessary to reduce significantly the number of new infections in the region.

show abstract

Section: Epidemiology Of Hepatitis C In the Maghreb Regionmentioning

confidence: 99%

Hepatitis C virus infection in the Maghreb region

Ezzikouri

Pineau

Benjelloun

2013

Journal of Medical Virology

View full text Add to dashboard Cite

show abstract

A review of the infection-associated cancers in North African countries

Hussein

Anwar

Attaleb

et al. 2016

Infect Agents Cancer

View full text Add to dashboard Cite

Cancer is typically classified as a leading non-communicable disease; however, infectious agents, such as Helicobacter pylori (H. pylori), hepatitis B virus (HBV), hepatitis C virus (HCV) and human papilloma virus (HPV), contribute significantly to the pathogenesis of various cancers. Less developed countries, including countries of the North African (NA) region, endure the highest burden of infection-related cancers. The five most common infection-associated cancers in NA in order of incidence are bladder cancer, cervical cancer, liver cancer, stomach cancer, and nasopharyngeal carcinoma. This review aims to outline the epidemiologic pattern of infection-associated cancers in five NA countries (namely: Morocco, Algeria, Tunisia, Libya and Egypt) highlighting the similarities and differences across the region. The present study employed an initial literature review of peer-reviewed articles selected from PubMed, ScienceDirect and World Health Organization (WHO) databases based on key word searches without restriction on publication dates. Original research articles and reports written in French, as well as data from institutional reports and regional meeting abstracts were also included in this extensive review. Egypt, Libya, Tunisia, Algeria and Morocco were selected to be the focus of this review.

show abstract

L’hépatite virale C en hémodialyse : étude multicentrique ambispective de séroconversion et de prévalence

Cited by 2 publications

References 0 publications

Hepatitis C virus infection in the Maghreb region

Hepatitis C virus infection in the Maghreb region

A review of the infection-associated cancers in North African countries

Contact Info

Product

Resources

About